138 related articles for article (PubMed ID: 8385619)
21. Effect of several bicyclic peptide and cyclic pseudopeptide tachykinin NK2 receptor antagonists in the human isolated urinary bladder.
Giuliani S; Patacchini R; Lazzeri M; Benaim G; Turini D; Quartara L; Maggi CA
J Auton Pharmacol; 1996 Oct; 16(5):251-9. PubMed ID: 9023669
[TBL] [Abstract][Full Text] [Related]
22. NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtype.
Giuliani S; Barbanti G; Turini D; Quartara L; Rovero P; Giachetti A; Maggi CA
Eur J Pharmacol; 1991 Oct; 203(3):365-70. PubMed ID: 1723045
[TBL] [Abstract][Full Text] [Related]
23. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
Aharony D; Little J; Thomas C; Powell S; Berry D; Graham A
Mol Pharmacol; 1994 Jan; 45(1):9-19. PubMed ID: 8302285
[TBL] [Abstract][Full Text] [Related]
24. Tachykinins mediate contraction of the human lower esophageal sphincter in vitro via activation of NK2 receptors.
Huber O; Bertrand C; Bunnett NW; Pellegrini CA; Nadel JA; Nakazato P; Debas HT; Geppetti P
Eur J Pharmacol; 1993 Aug; 239(1-3):103-9. PubMed ID: 8223885
[TBL] [Abstract][Full Text] [Related]
25. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
26. Competitive antagonists discriminate between NK2 tachykinin receptor subtypes.
Maggi CA; Patacchini R; Giuliani S; Rovero P; Dion S; Regoli D; Giachetti A; Meli A
Br J Pharmacol; 1990 Jul; 100(3):589-92. PubMed ID: 2167737
[TBL] [Abstract][Full Text] [Related]
27. Characterization of tachykinin NK2 receptors in human urinary bladder.
Zeng XP; Moore KH; Burcher E
J Urol; 1995 May; 153(5):1688-92. PubMed ID: 7715011
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes.
Guard S; Watson SP; Maggio JE; Too HP; Watling KJ
Br J Pharmacol; 1990 Apr; 99(4):767-73. PubMed ID: 1694464
[TBL] [Abstract][Full Text] [Related]
29. Further evidence for the existence of NK2 tachykinin receptor subtypes.
Patacchini R; Astolfi M; Quartara L; Rovero P; Giachetti A; Maggi CA
Br J Pharmacol; 1991 Sep; 104(1):91-6. PubMed ID: 1664768
[TBL] [Abstract][Full Text] [Related]
30. Characterization of NK1 and NK2 tachykinin receptors in guinea-pig and rat bronchopulmonary and vascular systems.
Floch A; Fardin V; Cavero I
Br J Pharmacol; 1994 Mar; 111(3):759-68. PubMed ID: 7517328
[TBL] [Abstract][Full Text] [Related]
31. A new class of high affinity ligands for the neurokinin A NK2 receptor: psi (CH2NR) reduced peptide bond analogues of neurokinin A4-10.
Harbeson SL; Shatzer SA; Le TB; Buck SH
J Med Chem; 1992 Oct; 35(21):3949-55. PubMed ID: 1331450
[TBL] [Abstract][Full Text] [Related]
32. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
33. Autoradiographic localization of tachykinin NK2 and NK1 receptors in the guinea-pig lung, using selective radioligands.
Strigas J; Burcher E
Eur J Pharmacol; 1996 Sep; 311(2-3):177-86. PubMed ID: 8891598
[TBL] [Abstract][Full Text] [Related]
34. In vivo and in vitro pharmacology of SR 48,968, a non-peptide tachykinin NK2 receptor antagonist.
Maggi CA; Patacchini R; Giuliani S; Giachetti A
Eur J Pharmacol; 1993 Mar; 234(1):83-90. PubMed ID: 8386095
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a tachykinin peptide NK2 receptor transfected into murine fibroblast B82 cells.
van Giersbergen PL; Shatzer SA; Henderson AK; Lai J; Nakanishi S; Yamamura HI; Buck SH
Proc Natl Acad Sci U S A; 1991 Mar; 88(5):1661-5. PubMed ID: 1848006
[TBL] [Abstract][Full Text] [Related]
36. Primary structure and receptor-binding properties of a neurokinin A-related peptide from frog gut.
Wang Y; Badgery-Parker T; Lovas S; Chartrel N; Vaudry H; Burcher E; Conlon JM
Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):827-32. PubMed ID: 1332683
[TBL] [Abstract][Full Text] [Related]
37. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
Meini S; Patacchini R; Maggi CA
Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
[TBL] [Abstract][Full Text] [Related]
38. Pharmacological characterization of tachykinin-induced intracellular calcium rise in a human NK2 receptor transfected cell line.
Subramanian N; Ruesch C; Bertrand C
Biochem Biophys Res Commun; 1994 May; 200(3):1512-20. PubMed ID: 8185607
[TBL] [Abstract][Full Text] [Related]
39. Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors.
Gether U; Yokota Y; Emonds-Alt X; Brelière JC; Lowe JA; Snider RM; Nakanishi S; Schwartz TW
Proc Natl Acad Sci U S A; 1993 Jul; 90(13):6194-8. PubMed ID: 7687062
[TBL] [Abstract][Full Text] [Related]
40. On the presence of NK2 receptor subtypes in peripheral and central tissues.
Watling KJ; Guard S; Krause JE; Takeda Y; Quirion R; Zarnegar R; Pain D; Franks R
Regul Pept; 1993 Jul; 46(1-2):311-3. PubMed ID: 8210495
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
